(Q35987460)

English

Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

ocular hypertension

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Steven T Simmons

1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Monte S Dirks

2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Robert J Noecker

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

language of work or name

0 references

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Advances in Therapy

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

247-262

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1007%2FBF02850157

21 January 2018

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

1 reference

https://api.crossref.org/works/10.1007%2FBF02850157

21 January 2018

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

1 reference

https://api.crossref.org/works/10.1007%2FBF02850157

21 January 2018

Answers from the ocular hypertension treatment study.

1 reference

https://api.crossref.org/works/10.1007%2FBF02850157

21 January 2018

Statistics notes: Absence of evidence is not evidence of absence

1 reference

https://api.crossref.org/works/10.1007%2FBF02850157

21 January 2018

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FBF02850157

21 January 2018

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1007%2FBF02850157

21 January 2018

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FBF02850157

21 January 2018

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

https://api.crossref.org/works/10.1007%2FBF02850157

21 January 2018

One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1007%2FBF02850157

21 January 2018

Identifiers

10.1007/BF02850157

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35987460&oldid=2198030933"